Scalable, Affordable Peptides for Skincare, Beauty & Consumer Health
Most of the peptides the industry wants are out of reach — too large, too complex, or too expensive to produce using chemical synthesis.
That’s where Phenotypeca comes in.
Our proprietary QTL technology enables recombinant manufacture of peptides that are impossible or uneconomical to produce using traditional chemical synthesis — giving you reliable access to high-quality peptides at commercial scale, with the economics your business needs.
Why Choose Phenotypeca?
- Access peptides others can’t make – complex or large sequences beyond the reach of chemical synthesis.
- Rapid feasibility check – submit your peptide and we’ll quickly confirm if it’s viable for recombinant manufacture.
- Secure IP – proprietary strains protected by patents, with optional exclusivity for your peptide.
- Sustainability advantage – lower energy use, minimal solvent waste, and a cleaner production story for conscious consumers.
- Validated performance – upfront reference standards, purity levels, and analytics agreed before full supply.
What We Offer
- Ingredient Supply – Bulk recombinant peptide production at commercial scale.
- Custom Solutions – Tailored development for your proprietary peptides.
- Innovation Access – Exclusive use of Phenotypeca’s own pipeline of peptides with defined consumer benefits.
We work across skincare, beauty, supplements, cosmeceuticals, and adjacent consumer health categories.
Why Switch to Recombinant?
Chemical synthesis is expensive, energy-intensive, and generates significant solvent waste — plus it struggles to scale for peptides with ~30 or more amino acids.
Recombinant manufacturing solves these challenges, opening access to peptides that enable next-generation formulations while delivering a strong sustainability narrative for your brand.
